Sarvam is thrilled to announce that it has successfully raised 53,600,000 in funding—a significant achievement that marks a major milestone in our journey toward building reliable, performant, enterprise-grade AI systems at scale for India. This investment propels our mission of developing the full-stack for generative AI tailored to the rich and diverse technological landscape of the country. Our strategic vision is centered on three key pillars: Models, Platform, and Ecosystem. With this infusion of capital, we will accelerate our efforts in developing both efficient, large-scale Indic language models and bespoke enterprise models that cater specifically to the unique linguistic and operational requirements of our market. Moreover, the funding will enable us to further enhance our enterprise-grade platform, empowering organizations to innovate rapidly and deploy creative, high-performance generative AI applications at scale. We are committed to not only advancing our proprietary capabilities but also contributing meaningfully to the broader AI community by supporting open-source models and datasets. This initiative will also bolster our leadership in large-scale data curation for public good, creating a robust ecosystem that benefits the entire development community. The enthusiasm and belief shown by our investors underscore the transformative potential of AI in driving future growth and efficiency in various sectors, reaffirming our commitment to pioneering solutions that address real-world challenges. With this new chapter, Sarvam is poised to set new benchmarks in the AI/ML landscape, further establishing itself as a key player in harnessing the power of generative AI to shape a smarter, more connected India.
Building India's AI Future: Sarvam Raises â‚ą53.6M in Series A to Power Enterprise-Grade Generative AI Solutions
Recently funded · $53.6M Series aSoftware Development
Get the full Sarvam company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Plantopia Bio.
At Plantopia, we are pioneering a new era in sustainable protein production. Leveraging our proprietary "Plant as a Platform" technology, we transform plants into efficient and scalable bio-factories capable of producing complex functional proteins. Our innovative approach combines advances in molecular farming, controlled-environment agriculture, and plant genetics to deliver high-quality solutions that are cost-effective, sustainable, and versatile. The world faces significant challenges in meeting the growing demand for protein, with traditional animal-based and alternative production methods often falling short due to high costs, inefficiency, and environmental impact. Plantopia addresses these challenges head-on by reimagining how essential biocompounds are produced. Our plant-based solutions reduce resource consumption, environmental strain, and production costs while maintaining the quality and functionality of traditional proteins. Our first breakthrough is in producing plant-based casein, a protein essential to the functionality of dairy products, with applications in cheese and beyond. Identical in structure and functionality to its animal-derived counterpart, our casein unlocks new possibilities for plant-based dairy alternatives without compromising on taste or texture. Backed by a team of industry veterans and leading investors in food-tech, Plantopia is at the forefront of reshaping the future of food production. Join us as we pave the way for a sustainable, healthier planet by turning plants into powerful tools for innovation. Let’s grow a better future together.
$9.0M Unknown
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Tikva Allocell Pte Ltd Singapore | Series a | $8.0M | today |
| 2 |  TYBR Health United States | Series a | $30.0M | today |
